molnupiravir

The unit, based in the commercial hub of Shanghai, has built a research and development platform, as well as workshops with annual…

Merck added that Sinopharm is the only legally authorised distributor of Merck's COVID-19 anti-viral molnupiravir in China

Paxlovid, a combination of Pfizer's new pill with an older anti-viral ritonavir, was made available to thousands of people with…

The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed to at least that many doses, and could increase…

The recommendation is based on new data from six randomised controlled trials involving 4,796 patients. This is the largest…

Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the…

The study has been conducted jointly by Fortis C-DOC, G D Hospital and Diabetes Institute, Jawaharlal Nehru Medical College and…

It is not immediately clear if China is already in talks with Pfizer to procure the pill

The endorsement by EMA for a conditional approval, if followed as usual by the European Commission, allows EU member states to…

The step has been taken to increase broad access of COVID-19 treatment in 105 Low- and Middle- Income Countries (LMICs)